Events

DigitalHealthEurope Summit
SEP
Tue
28
SEP
Wed
29
SEP
Thu
30

This was 4 years ago

Location

Online

Programmes
Health Digital, Industry & Space Digital Europe Health

As the concluding peace of the DigitalHealthEurope project (DHE), which comes to an end in September 2021, a DHE Summit is organised to bring together EU policymakers, funders, digital health experts and other health stakeholders for forward-looking debates on digital transformation in the healthcare sector.

The Summit will focus on real-life transformations through digital health (Day 1), empowering citizens through health data (Day 2) and scaling up innovation through health data (Day 3).

The organiser, DigitalHealthEurope, is an EU-funded project (Horizon 2020 funding) with as main objective the deployment of digital solutions for person-centred integrated care.

More information and registration on the event website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.